Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,033 public trials 267 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

NCT07504458

Conditions
Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia, Acute Promyelocytic Leukemia (APL), +12 more
Locations
  • Quetzal Site 1 Duarte, California, United States
  • Quetzal Site 7 Los Angeles, California, United States
  • Quetzal Site 5 Stanford, California, United States
  • Quetzal Site 4 Buffalo, New York, United States
View all 18 locations
View Trial Details
Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • Arizona Cancer Center at UMC North ( Site 0018) Tucson, Arizona, United States
  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0016) Fresno, California, United States
  • Providence Medical Foundation ( Site 0087) Fullerton, California, United States
View all 776 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details

Related conditions